Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilberry extract for impaired twilight and night vision
NCT02194127Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 1998
- Primary completion
- Jun 1999
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of bilberry extract in night blindness, sponsored by Boehringer Ingelheim. Primary endpoint: Maximum velocity of dilatation of the pupil at 29 days. Started Nov 1998; status: completed.
02
Drugs
bilberry extract
03
Conditions
night blindness
Beyond the preview
Go deeper on NCT02194127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194127.